Skip to main content
Equibles
CRMD logo

CRMD · CorMedix Inc.

Track CRMD — free

Use CRMD with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$8.43 -0.04 (-0.47%) At close · Sep 4
Russell 2000 member Rebalance outlook locked
Market Cap
$657.07M
Shares
77.94M

CRMD metrics

71 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$8.43
Market cap
$657.07M

Price action

19 metrics
Price change (1W)
+1.6%
Price change (30D)
+12.3%
Price change (3M)
+0.8%
Price change (6M)
+30.5%
Price change (YTD)
-27.5%
Price change (1Y)
-34.1%
Trailing year
Price change (5Y)
+30.5%
52-week high
$13.09
52-week low
$6.25
Change from 52-week high
-35.6%
Change from 52-week low
+34.9%
Annualized volatility
62.7%
Beta
1.2
RSI (14D)
55.8
Price vs SMA 50
+4.7%
Price vs SMA 200
+2.1%
Avg volume (3M)
1.28M
Relative volume
0.6
Average dollar volume
$10.45M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
77.94M

Valuation

12 metrics
P / E (TTM)
3.9
Trailing earnings · reciprocal yield 25.9%
PEG ratio
1.1
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
1.5×
reciprocal yield 68.9%
P / book
1.5
reciprocal yield 68.7%
FCF yield
37.3%
TTM · current market cap
Buyback yield
—
P / FCF
2.7
reciprocal yield 37.3%
P / operating cash flow
2.6
reciprocal yield 37.8%
Earnings yield
27.9%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-13

Profitability

9 metrics
Gross margin
82.8%
Operating margin
47.0%
Trailing 12 months
Net margin
40.5%
Gross profit (TTM)
$382.64M
Operating profit (TTM)
$217.04M
Net income (TTM)
$187.17M
Trailing 12 months
Diluted EPS (TTM)
$2.18
FCF margin
54.2%
Effective tax rate
8.0%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$1.06

Growth

11 metrics
Revenue growth YoY
+156.5%
Year over year
Net income growth YoY
+31.1%
Revenue (TTM)
$462.25M
Trailing 12 months
EPS growth YoY
+3.6%
Shares change YoY
+28.6%
Year over year · more shares
Revenue CAGR (3Y)
+1,582.8%
Revenue CAGR (5Y)
+319.7%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
40.6%
Return on assets
20.7%
Debt / equity
—
Current ratio
2.6
EBITDA (TTM)
—
Free cash flow (TTM)
$250.42M
Quick ratio
2.4
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$256.69M
Latest balance sheet
Cash & equivalents
$256.69M
Total assets
$904.05M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$253.94M
Capital expenditures (TTM)
$3.52M
R&D (TTM)
$27.59M
SG&A (TTM)
$43.24M
Stock compensation (TTM)
$16.32M
R&D / revenue
6.0%
Stock compensation / revenue
3.5%

Ownership (13F)

3 metrics
13F filers
197
13F filer change QoQ
+4
Institutional ownership
58.9%

Short interest

3 metrics
Short interest
22.0%
Latest settlement · 11.1 days to cover
Days to cover
11.1d
Short-squeeze score
83 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1410098 CUSIP 21900C308 13F (30d) 156 filings 152 filers Visit website Investor relations